Ultralife Corp (ULBI) Reports a net loss for Q4 FY25

Ultralife Corp (ULBI) Reports a net loss for Q4 FY25

Ultralife Corp (ULBI) reported Q4 2025 gaap earnings of $0.01 per share. No consensus estimate was available for comparison. Top-line…

Protara Therapeutics, Inc. (TARA) Reports Narrower Loss for Q4

Protara Therapeutics, Inc. (TARA) posted a Q4 2025 gaap loss of $0.37 per share, wider than the -$0.31 expected loss…

Apyx Medical Corporation (APYX) Reports a Net Loss for Q4 FY25

Apyx Medical Corporation (APYX), an energy technology company that designs and manufactures electrosurgical equipment and medical devices, reported fourth ...

Esperion Therapeutics, Inc (ESPR) Misses Q4 EPS Estimates

**BREAKING: Esperion Therapeutics Reports Q4 2025 Earnings Miss**

Inspired Entertainment, Inc (INSE) Misses Q4 EPS Estimates

Inspired Entertainment, Inc (INSE) reported Q4 2025 gaap earnings of -$0.18 per share, missing the $0.21 consensus estimate (miss by…

DNTH Stock Jumps 21.5% Despite Wider-Than-Expected Q4 Loss as Pipeline Prospects Fuel Rally

Dianthus Therapeutics posts wider-than-expected Q4 loss of $1.43/share on collapsing revenue, yet shares surge 21.5% on pipeline optimism.

SuRo Capital Corp (SSSS) Reports Wider Loss Q4 EPS Estimates by 10.0%

**SuRo Capital Corp Reports Wider-Than-Expected Q4 Loss**

Tenax Therapeutics Inc (TENX) Reports Q4 Earnings

**Tenax Therapeutics Reports Q4 2025 Results**

Bloom Energy (BE) Surges 12% Despite Adjusted Loss of $0.30 Per Share, Weak Q1 Outlook

Bloom Energy posts GAAP EPS beat at $0.45 vs $0.30 estimate, but adjusted EPS of -$0.30 and weak Q1 guidance…

DENTSPLY SIRONA (XRAY) Insider Gregory T. Lucier Buys 15,000 Shares at $12.45, Boosting Stake 30%

Gregory T. Lucier purchased 15,000 shares at $12.445, deploying $186,675 to increase his stake by 30% to 65,000 shares.